These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12138172)

  • 1. High level expression of recombinant porcine coagulation factor VIII.
    Doering CB; Healey JF; Parker ET; Barrow RT; Lollar P
    J Biol Chem; 2002 Oct; 277(41):38345-9. PubMed ID: 12138172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion.
    Doering CB; Healey JF; Parker ET; Barrow RT; Lollar P
    J Biol Chem; 2004 Feb; 279(8):6546-52. PubMed ID: 14660593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-Domain deleted recombinant coagulation factor VIII modified with monomethoxy polyethylene glycol.
    Röstin J; Smeds AL; Akerblom E
    Bioconjug Chem; 2000; 11(3):387-96. PubMed ID: 10821655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and functional characterization of Factor VIII-delta II, a new recombinant Factor VIII lacking most of the B-domain.
    Bihoreau N; Paolantonacci P; Bardelle C; Fontaine-Aupart MP; Krishnan S; Yon J; Romet-Lemonne JL
    Biochem J; 1991 Jul; 277 ( Pt 1)(Pt 1):23-31. PubMed ID: 1906711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gene expression of coagulation factor VIII in mammalian cell lines.
    Chen C; Fang XD; Zhu J; Wu XF; Zhang ZC; Gu JX; Wang ZY; Chi CW
    Thromb Res; 1999 Jul; 95(2):105-15. PubMed ID: 10418799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant factor VIII SQ--stability of VIII: C in homogenates from porcine, monkey and human subcutaneous tissue.
    Fatouros A; Lidén Y; Sjöström B
    J Pharm Pharmacol; 2000 Jul; 52(7):797-805. PubMed ID: 10933130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.
    Sandberg H; Almstedt A; Brandt J; Gray E; Holmquist L; Oswaldsson U; Sebring S; Mikaelsson M
    Thromb Haemost; 2001 Jan; 85(1):93-100. PubMed ID: 11204595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid residues 721-729 are required for full factor VIII activity.
    Kjalke M; Heding A; Talbo G; Persson E; Thomsen J; Ezban M
    Eur J Biochem; 1995 Dec; 234(3):773-9. PubMed ID: 8575434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of recombinant human factor VIII.
    Eaton DL; Hass PE; Riddle L; Mather J; Wiebe M; Gregory T; Vehar GA
    J Biol Chem; 1987 Mar; 262(7):3285-90. PubMed ID: 3102485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel forms of B-domain-deleted recombinant factor VIII molecules. Construction and biochemical characterization.
    Lind P; Larsson K; Spira J; Sydow-Bäckman M; Almstedt A; Gray E; Sandberg H
    Eur J Biochem; 1995 Aug; 232(1):19-27. PubMed ID: 7556150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing rDNA products for treatment of hemophilia A.
    Kaufman RJ
    Trends Biotechnol; 1991 Oct; 9(10):353-9. PubMed ID: 1367761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Production of factor VIII by genetic techniques].
    Neutzling O
    Beitr Infusionsther; 1993; 31():38-43. PubMed ID: 7693262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural study of the sugar chains of porcine factor VIII--tissue- and species-specific glycosylation of factor VIII.
    Hironaka T; Furukawa K; Esmon PC; Yokota T; Brown JE; Sawada S; Fournel MA; Kato M; Minaga T; Kobata A
    Arch Biochem Biophys; 1993 Dec; 307(2):316-30. PubMed ID: 8274017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile.
    Pahl S; Pavlova A; Driesen J; Müller J; Pötzsch B; Oldenburg J
    Haemophilia; 2013 May; 19(3):392-8. PubMed ID: 23252674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional importance of tyrosine sulfate residues within recombinant factor VIII.
    Pittman DD; Wang JH; Kaufman RJ
    Biochemistry; 1992 Apr; 31(13):3315-25. PubMed ID: 1554716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vector platform for production of bioengineered recombinant coagulation factor VIII.
    Spencer HT; Denning G; Gautney RE; Dropulic B; Roy AJ; Baranyi L; Gangadharan B; Parker ET; Lollar P; Doering CB
    Mol Ther; 2011 Feb; 19(2):302-9. PubMed ID: 21081907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.
    Kaufman RJ; Wasley LC; Dorner AJ
    J Biol Chem; 1988 May; 263(13):6352-62. PubMed ID: 3129422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.
    Mannucci PM; Franchini M
    Blood Transfus; 2017 Jul; 15(4):365-368. PubMed ID: 27483484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-apoptotic genes Aven and E1B-19K enhance performance of BHK cells engineered to express recombinant factor VIII in batch and low perfusion cell culture.
    Nivitchanyong T; Martinez A; Ishaque A; Murphy JE; Konstantinov K; Betenbaugh MJ; Thrift J
    Biotechnol Bioeng; 2007 Nov; 98(4):825-41. PubMed ID: 17514750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.